[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @Andre_AGTC Andre-ACGT Andre-ACGT posts on X about $xene, $prax, $rvmd, $kymr the most. They currently have XXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours. ### Engagements: XXXXX [#](/creator/twitter::1477330488960368642/interactions)  - X Week XXXXXXX +198% - X Month XXXXXXX -XX% - X Months XXXXXXXXX +24% - X Year XXXXXXXXX +10% ### Mentions: XX [#](/creator/twitter::1477330488960368642/posts_active)  - X Week XXX -XX% - X Month XXX +5.50% - X Months XXXXX +19% - X Year XXXXX +44% ### Followers: XXXXX [#](/creator/twitter::1477330488960368642/followers)  - X Week XXXXX +0.31% - X Month XXXXX +0.88% - X Months XXXXX +14% - X Year XXXXX +24% ### CreatorRank: XXXXXXX [#](/creator/twitter::1477330488960368642/influencer_rank)  ### Social Influence **Social category influence** [finance](/list/finance) XXXXX% [stocks](/list/stocks) XXXX% [technology brands](/list/technology-brands) XXXX% [social networks](/list/social-networks) XXXX% **Social topic influence** [$xene](/topic/$xene) #1, [$prax](/topic/$prax) #8, [$rvmd](/topic/$rvmd) #1, [$kymr](/topic/$kymr) #2, [$krys](/topic/$krys) #2, [$mdgl](/topic/$mdgl) #2, [$idya](/topic/$idya) #17, [$bbio](/topic/$bbio) #1, [dec](/topic/dec) #2360, [$axsm](/topic/$axsm) #2 **Top accounts mentioned or mentioned by** [@physioo](/creator/undefined) [@bioinvestor24](/creator/undefined) [@saicharanaitha](/creator/undefined) [@lpessa7654](/creator/undefined) [@maximusholla](/creator/undefined) [@joserestonva](/creator/undefined) [@grok](/creator/undefined) [@pharmdca](/creator/undefined) [@bowtiedbiotech](/creator/undefined) [@andersresearch](/creator/undefined) [@wallstsai](/creator/undefined) [@garywhi13830766](/creator/undefined) [@pacha8x](/creator/undefined) [@deepsouthdoctor](/creator/undefined) [@fwcweather](/creator/undefined) [@towiu2](/creator/undefined) [@biopharmiq](/creator/undefined) [@quantumup1](/creator/undefined) [@bananaoncology](/creator/undefined) [@biotech2k1](/creator/undefined) **Top assets mentioned** [Xenon Pharmaceuticals Inc (XENE)](/topic/$xene) [Praxis Precision Medicines, Inc. Common Stock (PRAX)](/topic/$prax) [Revolution Medicines, Inc. Common Stock (RVMD)](/topic/$rvmd) [Kymera Therapeutics, Inc. Common Stock (KYMR)](/topic/$kymr) [Krystal Biotech, Inc. Common Stock (KRYS)](/topic/$krys) [Madrigal Pharmaceuticals, Inc. Common Stock (MDGL)](/topic/$mdgl) [IDEAYA Biosciences, Inc. Common Stock (IDYA)](/topic/$idya) [BridgeBio Pharma, Inc. Common Stock (BBIO)](/topic/$bbio) [Axsome Therapeutics, Inc (AXSM)](/topic/$axsm) [MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX)](/topic/$mltx) [Crinetics Pharmaceuticals, Inc. (CRNX)](/topic/$crnx) [Nuvalent, Inc. Class A Common Stock (NUVL)](/topic/$nuvl) [Travere Therapeutics, Inc. Common Stock (TVTX)](/topic/$tvtx) [Scholar Rock Holding Corporation Common Stock (SRRK)](/topic/$srrk) [Biohaven Pharmaceutical Holding Company Ltd. (BHVN)](/topic/$bhvn) [Wave Life Sciences Ltd. Ordinary Shares (WVE)](/topic/$wve) [Eli Lilly and Company (LLY)](/topic/$lly) [Neurocrine Biosciences, Inc. (NBIX)](/topic/$nbix) [Alnylam Pharmaceuticals, Inc. (ALNY)](/topic/$alny) [Mirum Pharmaceuticals, Inc. Common Stock (MIRM)](/topic/$mirm) [Intra-Cellular Therapies Inc. (ITCI)](/topic/$itci) [Blueprint Medicines Corporation (BPMC)](/topic/$bpmc) [Viking Therapeutics, Inc (VKTX)](/topic/$vktx) [Janux Therapeutics, Inc. Common Stock (JANX)](/topic/$janx) [United Community Banks, Inc. (UCB)](/topic/$ucb) [Cidara Therapeutics, Inc. (CDTX)](/topic/$cdtx) [Terns Pharmaceuticals, Inc. Common Stock (TERN)](/topic/$tern) [Pfizer, Inc. (PFE)](/topic/$pfe) [Catalyst Pharmaceutical Inc. (CPRX)](/topic/$cprx) [Acadia Pharmaceuticals Inc. (ACAD)](/topic/$acad) [Corcept Therapeutics Inc. (CORT)](/topic/$cort) [Bitcoin Incognito (XBI)](/topic/$xbi) [Merck & Co., Inc. (MRK)](/topic/$mrk) [Adverum Biotechnologies, Inc. Common Stock (ADVM)](/topic/$advm) [AbbVie Inc (ABBV)](/topic/$abbv) ### Top Social Posts Top posts by engagements in the last XX hours "$KYMR STAT6 is the only specific transcription factor in the IL-4/13 pathway blocking TH2 inflammation Key catalysts Ph1b AD data in Q4" [X Link](https://x.com/Andre_AGTC/status/1974870937574289438) 2025-10-05T16:14Z 6208 followers, 6770 engagements "$TVTX another tweet again well Only +150% so far but more is comming Already profitable revenue and cash growing nicely Jan PDUFA and launch in ESGS Still valid the holy grail in investing "Derisked opportunity at discount valuation"" [X Link](https://x.com/Andre_AGTC/status/1988268068292747565) 2025-11-11T15:30Z 6206 followers, 5415 engagements "$TVTX best idea of Gugg I knew that since the stock was trading at 14s" [X Link](https://x.com/Andre_AGTC/status/1988818439931326934) 2025-11-13T03:57Z 6206 followers, 2462 engagements "Baker Bros $MDGL #3 +8.4% (my #1) $RVMD #8 +1% (my #5) $IDYA #18 +55% (my #20+) $ABVX #24 New (my #15+) Good selection. I was adding to the same stocks" [X Link](https://x.com/Andre_AGTC/status/1989483497547841911) 2025-11-15T00:00Z 6206 followers, 1695 engagements "$RVMD This tip keep aging well X in XXX mo and counting It was one of the best low risk play Still 5mo until expiration enough to cover ph3 data and JMP conference IMO good platform aquisition. Pricy but worth it" [X Link](https://x.com/Andre_AGTC/status/1990854244962844675) 2025-11-18T18:46Z 6207 followers, 2810 engagements "$TVTX Anothe ATH at XXXXX Profitable revenue and cash growing Jan PDUFA and launch in ESGS Did I call it at 14.50: "Derisked opportunity at discount valuation"" [X Link](https://x.com/Andre_AGTC/status/1990858722734641229) 2025-11-18T19:04Z 6206 followers, 2025 engagements "$PRAX respons to Culper short report HCW will host an expert call on Ulixacaltamide Data with statistician Prof. Chuck McCullogh Uni of California plus Souza PRAX CEO Nov 22'25 1:00pm EST We will see some volatility Monday" [X Link](https://x.com/anyuser/status/1991691063535513681) 2025-11-21T02:12Z X followers, 8193 engagements "My precommercial bios w a ton of cash is the team of the year. Return since this post $RVMD +105% $CRNX +50% $NUVL +70% $IDYA +90% Coincidence" [X Link](https://x.com/Andre_AGTC/status/1992985018357235910) 2025-11-24T15:53Z 6207 followers, 6366 engagements "Top near term binary events My interest is in $BBIO $RVMD $IDYA $SRRK $BHVN MDD is a toss-up but worth playing" [X Link](https://x.com/Andre_AGTC/status/1995491194881945893) 2025-12-01T13:52Z 6206 followers, 10.1K engagements "I am getting regular calls from Fidelity They say - my accont is not diversified (70% in biotech) and my top X are above the recommended max allocation My answer is - diversification is a mother of mediocracy Next time they call I will refer them to Stanley Druckenmiller" [X Link](https://x.com/Andre_AGTC/status/1996386257375838493) 2025-12-04T01:09Z 6205 followers, 4201 engagements "$MLTX FDA meeting in mid Dec is about if they can fill NDA with one successful trail If approved lower efficacy may get compensated by dosing and administration convenience vs Bimzelx ($UCB) IMO approval is possible bc the second trail failed due to high placebo response" [X Link](https://x.com/Andre_AGTC/status/1996603977253687493) 2025-12-04T15:34Z 6205 followers, 4676 engagements "$PRAX Some rev estimates from mid Oct Innitial target population 6B -12B assuming modest 20k/y price It can double if mild cases ( Scale I) are added. Massive TAM justifying at least 2x of the current valuation .but some FDA uncertainty still remain until approval" [X Link](https://x.com/Andre_AGTC/status/1997043684823515480) 2025-12-05T20:41Z 6207 followers, 2213 engagements "When you see this the first reaction is: "Why I want to invest in anything else but biotech"" [X Link](https://x.com/Andre_AGTC/status/1997114080843165772) 2025-12-06T01:21Z 6206 followers, 12.9K engagements "@TheBio_Hunter Agree. I should redo it from the max not from close Agree about $WVE. I would add $FULC and $TERN. Great data but too early to get really excited" [X Link](https://x.com/Andre_AGTC/status/1998761108078023017) 2025-12-10T14:25Z 6225 followers, XXX engagements "Sounds easy First in class with unique MOA and large TAM I had XX aquisition in my port in the last 2.5y and most of them fit this description From my current holding IMO $XENE $MDGL $KRYS $BBIO $RVMD $NKTR fit these requirements" [X Link](https://x.com/Andre_AGTC/status/1978264470129414324) 2025-10-15T00:59Z 6222 followers, 9061 engagements "$ADVM (NP) aquired with CVR 2x of the cash per share. It must be a record CBR to share ratio Bought some $FDMT for $XX at open. It may run up in sympathy" [X Link](https://x.com/Andre_AGTC/status/1981721907880730816) 2025-10-24T13:58Z 6218 followers, 3383 engagements "$NBIX $2.1B cash profitable looking to grow the business. $XENE fits well but too big at 3.3B $PRAX are even expensive at 5B MC $VTYX 540M will work for them BTW why VTYX didn't raise capital after the cardio data Just asking no speculations" [X Link](https://x.com/Andre_AGTC/status/1983306565823381528) 2025-10-28T22:55Z 6222 followers, 4823 engagements "$ALNY Q3 ER Revenue $851M (Q2 $672M) TTR Revenues $XXX (Q2 $544M) 2025 Guidance $3B (was $2.7B) Cash 2.7B (Q2 2.86B) Profit 251M" [X Link](https://x.com/Andre_AGTC/status/1983883802771640428) 2025-10-30T13:08Z 6212 followers, 2051 engagements "$IDYA Many catalysts near term" [X Link](https://x.com/Andre_AGTC/status/1987181588392911188) 2025-11-08T15:33Z 6222 followers, 1816 engagements "Keeping w/ the tradition - XX weeks in a row the trading accont at ATH Almost all top stocks at ATH Comments $PRAX got hit by a short report. Let's see if Mon call can bring some clarity $MIRM soft Q3 stopped the momentum $XENE rump up to ph3 data $NKTR temp. consolidating" [X Link](https://x.com/Andre_AGTC/status/1991995905499869377) 2025-11-21T22:23Z 6222 followers, 3243 engagements "$AXSM This prediction didn't age well so far - AXSM is still not aquired. But on the bright side AXSM is +110% since the MDD settlement with TEVA and the tweet below Anyway I would take +110% gain any time without complaining What about you Smo not happy" [X Link](https://x.com/Andre_AGTC/status/1992729386865545693) 2025-11-23T22:58Z 6207 followers, 2880 engagements "$AXSM MC 7B Nice plot showing 16.5B peak sales potential They are alredy executing on the second level with the migrane approval. The next big catalysts is NDA in ADA an potential acceptance FDA letter and PDUFA day" [X Link](https://x.com/Andre_AGTC/status/1992744256394686779) 2025-11-23T23:57Z 6208 followers, 3632 engagements "$IDYA Key catalysts MUM readout by YE /Q1 which can confirm the platform Becoming commercial company by YE of 2026" [X Link](https://x.com/Andre_AGTC/status/1992939111586648504) 2025-11-24T12:51Z 6222 followers, 1431 engagements "$XENE X posters on the AEA Dec X to X. Focus will be OLE seizures data It may give a clue how the main trail in FOS will read early next year" [X Link](https://x.com/Andre_AGTC/status/1993384702162743688) 2025-11-25T18:22Z 6222 followers, 1230 engagements "@SaicharanAitha @Anders_Research $VTYX It was a fabulous run from X to XX. So taking profit is natural Make sure to buy something promising with the proceeds. May I recomend to park the cash in $XENE" [X Link](https://x.com/Andre_AGTC/status/1993442741616017840) 2025-11-25T22:12Z 6222 followers, XXX engagements "@SaicharanAitha @Anders_Research Currently $XENE is my 3rd position (after $MDGL and $KRYS) and I added yesterday if that can give you a courage to get back🙂" [X Link](https://x.com/Andre_AGTC/status/1993448711528366304) 2025-11-25T22:36Z 6222 followers, XXX engagements "$XENE (MC 3.4B) $PRAX (MC 4.7B) 2025 AES Dec 5-9 in Atlanta Both with 7-8 presentations in epilepcy Both will present OLE data in FOS. Different MOA" [X Link](https://x.com/Andre_AGTC/status/1994405007744016836) 2025-11-28T13:56Z 6222 followers, 1366 engagements "$JANX from +50% to -XX% in AH The data look confusing and the presentation is messy I have Jan 20c. If a miracle happens like good XXX data it might have some value by mid Jan" [X Link](https://x.com/Andre_AGTC/status/1995706165376733311) 2025-12-02T04:06Z 6221 followers, 4617 engagements "@jfais20 @JoseRestonVA If you allow me to rephrase it: Hopefully more "welcome to biotech" M&A moments a la $ITCI $BPMC $VRNA $CDTX etc etc will keep us all excited about biotech investment opportunities" [X Link](https://x.com/Andre_AGTC/status/1995917663340573016) 2025-12-02T18:07Z 6222 followers, XXX engagements "$MLTX $XX holla. Cash 380M; EV 640M If allowed to file NDA in HS the stock may double. Worth the risk $AVTX Soon $XX holla. Cash 111M; EV 180M Another HS contender with Ph2 data in mid 2026 TAM is projected 8B in 2034 $UCB is dominant player" [X Link](https://x.com/Andre_AGTC/status/1996652872059290068) 2025-12-04T18:48Z 6222 followers, 2061 engagements "Single study is enough for approval Very positive for $AXSM (ADA) $PRAX (ET) $MLTX (HS)" [X Link](https://x.com/Andre_AGTC/status/1996673332272312384) 2025-12-04T20:09Z 6215 followers, 5814 engagements "$BBIO ACH ph3 data in q1'26" [X Link](https://x.com/Andre_AGTC/status/1996683277487509614) 2025-12-04T20:49Z 6215 followers, 1970 engagements "$PRAX SCN2A and SCN8A developmental and epileptic encephalopathies (DEEs) early stoped for efficacy It's NaV channel so we may see some sympathy in $XENE" [X Link](https://x.com/Andre_AGTC/status/1996705596284756327) 2025-12-04T22:18Z 6222 followers, 5292 engagements "$VKTX Todays FDA ruling about single trail requirement could speed up the drug approval process. Hope the pre-NDA FDA meeting will confirm that" [X Link](https://x.com/Andre_AGTC/status/1996755738434363410) 2025-12-05T01:37Z 6222 followers, 5166 engagements "$ABVX Good point why $ABBV isn't a potential aquirer. IMO nobody currently is before the maintenance data due to some concerns about elevated miR-124 level. Could it bring surprises in long term like cardiac issues Long-term safety data are needed before any BO" [X Link](https://x.com/Andre_AGTC/status/1996806442821755366) 2025-12-05T04:58Z 6222 followers, 10.2K engagements "$KRYS Retweeting a post which got X like X retweet X reply Many missed the point that the PTD from FDA is a game changer making any future NDAs faster and with higher probability of approval And the stock is up 50%+ since then" [X Link](https://x.com/Andre_AGTC/status/1997008537369895232) 2025-12-05T18:21Z 6215 followers, 3064 engagements "@physioo Thanks $KRYS is not a popular name Which is strange because it's text book investment for small investors- first and only treatment in something Plus HSV platform nobody even consider to develop Monopoly in its purest form" [X Link](https://x.com/Andre_AGTC/status/1997107575435735285) 2025-12-06T00:55Z 6215 followers, XXX engagements "$PRAX H.C.W: the pipeline is overlooked & underappreciated "We can't recall an instance where a biotech company got its first two approvals of drugs developed organically and both with blockbuster potential within a span of just a few months" Still not approved but on the way" [X Link](https://x.com/Andre_AGTC/status/1997280001893478733) 2025-12-06T12:20Z 6222 followers, 3126 engagements "Two interesting data tomorrow Dec 7'25. $KURA Ph X Ziftomenib data (MEN1 Inhibitor - Small Molecule) in Acute Myeloid Leukemia $NRIX Ph X Waldenstrom Macroglobulinemia Data for Bexobrutideg (Btk Degrader - Small Molecule)" [X Link](https://x.com/Andre_AGTC/status/1997666114487152699) 2025-12-07T13:54Z 6222 followers, 2941 engagements "$VTYX S1P1 vs $ABVX miR-124 Data looks comparable but VTYX program is practically on hold until they found a partner While data were promising they probably decided that going after NLRP3 is less risky Note that S1P1 & miR-124 both might have theoretically cardiac issues" [X Link](https://x.com/Andre_AGTC/status/1997790820750246051) 2025-12-07T22:10Z 6222 followers, 5797 engagements "@WallStSai @GaryWhi13830766 @bioinvestor24 @pacha_8x IMO $PFE wanted low risk drug with some differenciation to $LLY. Small Molecule from $GPCR was too risky" [X Link](https://x.com/Andre_AGTC/status/1997837505178337361) 2025-12-08T01:15Z 6222 followers, 4819 engagements "@Pharmdca Great point. Holding shares through binary events can be a nightmare That's why I prefer holding only options At bad data the loss is limited At good data - convert to shares at expiration to full position For example I have $PRAX Jan 30c. Small 10k lotto currently 150k" [X Link](https://x.com/Andre_AGTC/status/1997846479013306692) 2025-12-08T01:51Z 6219 followers, 1183 engagements "$KYMR Stront AD data Mean XX% EASI reduction and mean XX% peak pruritus NRS reduction Patients with comorbid asthma with median XX% FeNO reduction in Allergic rhinitis with significant symptom and quality-of-life benefits Beat Dupi and on par with JAK 👍🤩 @BowTiedBiotech" [X Link](https://x.com/Andre_AGTC/status/1998019806151512175) 2025-12-08T13:20Z 6222 followers, 1373 engagements "Long idea for 2026 Stay invested in protein degrader bios $KYMR $GLUE $NRIX The tweet to be revisited Dec 2026" [X Link](https://x.com/Andre_AGTC/status/1998046083449270375) 2025-12-08T15:04Z 6221 followers, 1755 engagements "@DeepSouthDoctor Got it. Short position is a bit too risky to me. Big loss if the teade goes against you. Buying puts - risk is limited to the put price you pay. For example Dec XX puts are +70% today. Better return at low risk" [X Link](https://x.com/Andre_AGTC/status/1998417122482151603) 2025-12-09T15:39Z 6222 followers, XXX engagements "Update top 10+10 (after $VRNA BO) $MDGL NASH $AXSM CNS MDD $XENE CNS seizures $KRYS GT DEB $VKTX metabolic $MIRM IBAT rare $MLTX I&I IL17A/F $SRRK TGFb $ALNY RNAi $RVMD RASmuti $BBIO $CRNX $CPRX $ABEO $KYMR $NUVL $IMCR $ACAD $CORT $NBIX" [X Link](https://x.com/Andre_AGTC/status/1945600827659264000) 2025-07-16T21:45Z 6223 followers, 42.1K engagements "Q4 Update top 10+10 $MDGL NASH $AXSM CNS MDD $XENE CNS seizures $KRYS GT DEB $MIRM IBAT rare $RVMD RASmuti $CRNX endocrine $BBIO ATTR $SRRK TGFb $ALNY RNAi $CPRX $ABEO $CORT $KYMR $NUVL $QURE $IMCR $NBIX $VKTX $MLYS" [X Link](https://x.com/Andre_AGTC/status/1973033636619555030) 2025-09-30T14:34Z 6225 followers, 18.8K engagements "$CRNX vs $TGTX pipeline" [X Link](https://x.com/Andre_AGTC/status/1987184159174115481) 2025-11-08T15:43Z 6223 followers, 5050 engagements "@bioinvestor24 $TNGX is more advanced in PRMT5" [X Link](https://x.com/Andre_AGTC/status/1995327138522616201) 2025-12-01T03:00Z 6223 followers, XXX engagements "$IDYA Collaboration Termination: GSK ended its agreement with Ideaya Biosciences for two clinical programs Pol Theya & Werner Hmm not a good news" [X Link](https://x.com/Andre_AGTC/status/1997091518243602648) 2025-12-05T23:51Z 6223 followers, 15.4K engagements "$ABEO first patient treatment with RDEB It company milestone Reminder- each treatment is 3.1M so easy to became profitable in short term Stayed tuned for the next two ERs I believe double digit by mid 2026" [X Link](https://x.com/Andre_AGTC/status/1998025091322630398) 2025-12-08T13:41Z 6223 followers, 2677 engagements "$GPCR Loking into GPCR data (oral GLP1) I start thinking that $PFE made another strategic mistake BTW selling GPCR at 5B mc is like missing half of the potential profit $MTSR got 9B for long acting peptide injection" [X Link](https://x.com/Andre_AGTC/status/1998050586860909019) 2025-12-08T15:22Z 6223 followers, 3782 engagements "$VTYX Interesting option play 5000 call contracts Mar 10c at ask for 1225K 5000 put contracts Mar 7.5p at bit for 750K It looks buying XX calls and selling XXX puts for total 500k Winn XX a loss X @grok is this trade bullish or bearish" [X Link](https://x.com/Andre_AGTC/status/1998097193174262195) 2025-12-08T18:27Z 6225 followers, 4645 engagements "Capital raise of all winners today $KYMR 500M cash after that 1.1B $GPCR 500M cash after that 1.3B $WVE 250M cash after that 450M $FULC 150M cash after that 350M $NRIX no raise cash 430M So investors has to find 3B. Getting it from other bios We may have a few -ve days" [X Link](https://x.com/Andre_AGTC/status/1998146738549338568) 2025-12-08T21:44Z 6225 followers, 13.3K engagements "$XENE Epilepcy OLE data Monthly reductions in seizure frequency of XXXX% among participants treated for XX months with XX% achieving X year of seizure freedom" [X Link](https://x.com/Andre_AGTC/status/1998163788839756036) 2025-12-08T22:52Z 6225 followers, 1488 engagements "$BHVN MDD ph2 data with Kv7 activator anytime now (expected q4'25) $XENE had mixed ph2 data with the same target last year in general positive. The bar is set so BHVN shoukd beat that or" [X Link](https://x.com/Andre_AGTC/status/1998395008664182820) 2025-12-09T14:11Z 6225 followers, 4768 engagements "Capital raise - all upsized small discount - strong demand $KYMR 500M -602M @ $XX /-1% $GPCR 500M -650M @ $XX /-3% $WVE 250M -350M @ $XX /-11% $FULC 150M- 175M @ $XXXX /-7% $DYN 300M -350M @ $XXXX / X% $VERA 200M -260M @ $XXXX /-7% $TERN 400M -650M @ $XX / -7%" [X Link](https://x.com/Andre_AGTC/status/1998746261445304522) 2025-12-10T13:26Z 6225 followers, 4451 engagements "$ABVX BO price is leaked- $XXX no CRV" [X Link](https://x.com/Andre_AGTC/status/1998772143794905450) 2025-12-10T15:09Z 6225 followers, 11.5K engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@Andre_AGTC Andre-ACGT
Andre-ACGT posts on X about $xene, $prax, $rvmd, $kymr the most. They currently have XXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours.
Engagements: XXXXX #
- X Week XXXXXXX +198%
- X Month XXXXXXX -XX%
- X Months XXXXXXXXX +24%
- X Year XXXXXXXXX +10%
Mentions: XX #
- X Week XXX -XX%
- X Month XXX +5.50%
- X Months XXXXX +19%
- X Year XXXXX +44%
Followers: XXXXX #
- X Week XXXXX +0.31%
- X Month XXXXX +0.88%
- X Months XXXXX +14%
- X Year XXXXX +24%
CreatorRank: XXXXXXX #
Social Influence
Social category influence finance XXXXX% stocks XXXX% technology brands XXXX% social networks XXXX%
Social topic influence $xene #1, $prax #8, $rvmd #1, $kymr #2, $krys #2, $mdgl #2, $idya #17, $bbio #1, dec #2360, $axsm #2
Top accounts mentioned or mentioned by @physioo @bioinvestor24 @saicharanaitha @lpessa7654 @maximusholla @joserestonva @grok @pharmdca @bowtiedbiotech @andersresearch @wallstsai @garywhi13830766 @pacha8x @deepsouthdoctor @fwcweather @towiu2 @biopharmiq @quantumup1 @bananaoncology @biotech2k1
Top assets mentioned Xenon Pharmaceuticals Inc (XENE) Praxis Precision Medicines, Inc. Common Stock (PRAX) Revolution Medicines, Inc. Common Stock (RVMD) Kymera Therapeutics, Inc. Common Stock (KYMR) Krystal Biotech, Inc. Common Stock (KRYS) Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) IDEAYA Biosciences, Inc. Common Stock (IDYA) BridgeBio Pharma, Inc. Common Stock (BBIO) Axsome Therapeutics, Inc (AXSM) MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) Crinetics Pharmaceuticals, Inc. (CRNX) Nuvalent, Inc. Class A Common Stock (NUVL) Travere Therapeutics, Inc. Common Stock (TVTX) Scholar Rock Holding Corporation Common Stock (SRRK) Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Wave Life Sciences Ltd. Ordinary Shares (WVE) Eli Lilly and Company (LLY) Neurocrine Biosciences, Inc. (NBIX) Alnylam Pharmaceuticals, Inc. (ALNY) Mirum Pharmaceuticals, Inc. Common Stock (MIRM) Intra-Cellular Therapies Inc. (ITCI) Blueprint Medicines Corporation (BPMC) Viking Therapeutics, Inc (VKTX) Janux Therapeutics, Inc. Common Stock (JANX) United Community Banks, Inc. (UCB) Cidara Therapeutics, Inc. (CDTX) Terns Pharmaceuticals, Inc. Common Stock (TERN) Pfizer, Inc. (PFE) Catalyst Pharmaceutical Inc. (CPRX) Acadia Pharmaceuticals Inc. (ACAD) Corcept Therapeutics Inc. (CORT) Bitcoin Incognito (XBI) Merck & Co., Inc. (MRK) Adverum Biotechnologies, Inc. Common Stock (ADVM) AbbVie Inc (ABBV)
Top Social Posts
Top posts by engagements in the last XX hours
"$KYMR STAT6 is the only specific transcription factor in the IL-4/13 pathway blocking TH2 inflammation Key catalysts Ph1b AD data in Q4"
X Link 2025-10-05T16:14Z 6208 followers, 6770 engagements
"$TVTX another tweet again well Only +150% so far but more is comming Already profitable revenue and cash growing nicely Jan PDUFA and launch in ESGS Still valid the holy grail in investing "Derisked opportunity at discount valuation""
X Link 2025-11-11T15:30Z 6206 followers, 5415 engagements
"$TVTX best idea of Gugg I knew that since the stock was trading at 14s"
X Link 2025-11-13T03:57Z 6206 followers, 2462 engagements
"Baker Bros $MDGL #3 +8.4% (my #1) $RVMD #8 +1% (my #5) $IDYA #18 +55% (my #20+) $ABVX #24 New (my #15+) Good selection. I was adding to the same stocks"
X Link 2025-11-15T00:00Z 6206 followers, 1695 engagements
"$RVMD This tip keep aging well X in XXX mo and counting It was one of the best low risk play Still 5mo until expiration enough to cover ph3 data and JMP conference IMO good platform aquisition. Pricy but worth it"
X Link 2025-11-18T18:46Z 6207 followers, 2810 engagements
"$TVTX Anothe ATH at XXXXX Profitable revenue and cash growing Jan PDUFA and launch in ESGS Did I call it at 14.50: "Derisked opportunity at discount valuation""
X Link 2025-11-18T19:04Z 6206 followers, 2025 engagements
"$PRAX respons to Culper short report HCW will host an expert call on Ulixacaltamide Data with statistician Prof. Chuck McCullogh Uni of California plus Souza PRAX CEO Nov 22'25 1:00pm EST We will see some volatility Monday"
X Link 2025-11-21T02:12Z X followers, 8193 engagements
"My precommercial bios w a ton of cash is the team of the year. Return since this post $RVMD +105% $CRNX +50% $NUVL +70% $IDYA +90% Coincidence"
X Link 2025-11-24T15:53Z 6207 followers, 6366 engagements
"Top near term binary events My interest is in $BBIO $RVMD $IDYA $SRRK $BHVN MDD is a toss-up but worth playing"
X Link 2025-12-01T13:52Z 6206 followers, 10.1K engagements
"I am getting regular calls from Fidelity They say - my accont is not diversified (70% in biotech) and my top X are above the recommended max allocation My answer is - diversification is a mother of mediocracy Next time they call I will refer them to Stanley Druckenmiller"
X Link 2025-12-04T01:09Z 6205 followers, 4201 engagements
"$MLTX FDA meeting in mid Dec is about if they can fill NDA with one successful trail If approved lower efficacy may get compensated by dosing and administration convenience vs Bimzelx ($UCB) IMO approval is possible bc the second trail failed due to high placebo response"
X Link 2025-12-04T15:34Z 6205 followers, 4676 engagements
"$PRAX Some rev estimates from mid Oct Innitial target population 6B -12B assuming modest 20k/y price It can double if mild cases ( Scale I) are added. Massive TAM justifying at least 2x of the current valuation .but some FDA uncertainty still remain until approval"
X Link 2025-12-05T20:41Z 6207 followers, 2213 engagements
"When you see this the first reaction is: "Why I want to invest in anything else but biotech""
X Link 2025-12-06T01:21Z 6206 followers, 12.9K engagements
"@TheBio_Hunter Agree. I should redo it from the max not from close Agree about $WVE. I would add $FULC and $TERN. Great data but too early to get really excited"
X Link 2025-12-10T14:25Z 6225 followers, XXX engagements
"Sounds easy First in class with unique MOA and large TAM I had XX aquisition in my port in the last 2.5y and most of them fit this description From my current holding IMO $XENE $MDGL $KRYS $BBIO $RVMD $NKTR fit these requirements"
X Link 2025-10-15T00:59Z 6222 followers, 9061 engagements
"$ADVM (NP) aquired with CVR 2x of the cash per share. It must be a record CBR to share ratio Bought some $FDMT for $XX at open. It may run up in sympathy"
X Link 2025-10-24T13:58Z 6218 followers, 3383 engagements
"$NBIX $2.1B cash profitable looking to grow the business. $XENE fits well but too big at 3.3B $PRAX are even expensive at 5B MC $VTYX 540M will work for them BTW why VTYX didn't raise capital after the cardio data Just asking no speculations"
X Link 2025-10-28T22:55Z 6222 followers, 4823 engagements
"$ALNY Q3 ER Revenue $851M (Q2 $672M) TTR Revenues $XXX (Q2 $544M) 2025 Guidance $3B (was $2.7B) Cash 2.7B (Q2 2.86B) Profit 251M"
X Link 2025-10-30T13:08Z 6212 followers, 2051 engagements
"$IDYA Many catalysts near term"
X Link 2025-11-08T15:33Z 6222 followers, 1816 engagements
"Keeping w/ the tradition - XX weeks in a row the trading accont at ATH Almost all top stocks at ATH Comments $PRAX got hit by a short report. Let's see if Mon call can bring some clarity $MIRM soft Q3 stopped the momentum $XENE rump up to ph3 data $NKTR temp. consolidating"
X Link 2025-11-21T22:23Z 6222 followers, 3243 engagements
"$AXSM This prediction didn't age well so far - AXSM is still not aquired. But on the bright side AXSM is +110% since the MDD settlement with TEVA and the tweet below Anyway I would take +110% gain any time without complaining What about you Smo not happy"
X Link 2025-11-23T22:58Z 6207 followers, 2880 engagements
"$AXSM MC 7B Nice plot showing 16.5B peak sales potential They are alredy executing on the second level with the migrane approval. The next big catalysts is NDA in ADA an potential acceptance FDA letter and PDUFA day"
X Link 2025-11-23T23:57Z 6208 followers, 3632 engagements
"$IDYA Key catalysts MUM readout by YE /Q1 which can confirm the platform Becoming commercial company by YE of 2026"
X Link 2025-11-24T12:51Z 6222 followers, 1431 engagements
"$XENE X posters on the AEA Dec X to X. Focus will be OLE seizures data It may give a clue how the main trail in FOS will read early next year"
X Link 2025-11-25T18:22Z 6222 followers, 1230 engagements
"@SaicharanAitha @Anders_Research $VTYX It was a fabulous run from X to XX. So taking profit is natural Make sure to buy something promising with the proceeds. May I recomend to park the cash in $XENE"
X Link 2025-11-25T22:12Z 6222 followers, XXX engagements
"@SaicharanAitha @Anders_Research Currently $XENE is my 3rd position (after $MDGL and $KRYS) and I added yesterday if that can give you a courage to get back🙂"
X Link 2025-11-25T22:36Z 6222 followers, XXX engagements
"$XENE (MC 3.4B) $PRAX (MC 4.7B) 2025 AES Dec 5-9 in Atlanta Both with 7-8 presentations in epilepcy Both will present OLE data in FOS. Different MOA"
X Link 2025-11-28T13:56Z 6222 followers, 1366 engagements
"$JANX from +50% to -XX% in AH The data look confusing and the presentation is messy I have Jan 20c. If a miracle happens like good XXX data it might have some value by mid Jan"
X Link 2025-12-02T04:06Z 6221 followers, 4617 engagements
"@jfais20 @JoseRestonVA If you allow me to rephrase it: Hopefully more "welcome to biotech" M&A moments a la $ITCI $BPMC $VRNA $CDTX etc etc will keep us all excited about biotech investment opportunities"
X Link 2025-12-02T18:07Z 6222 followers, XXX engagements
"$MLTX $XX holla. Cash 380M; EV 640M If allowed to file NDA in HS the stock may double. Worth the risk $AVTX Soon $XX holla. Cash 111M; EV 180M Another HS contender with Ph2 data in mid 2026 TAM is projected 8B in 2034 $UCB is dominant player"
X Link 2025-12-04T18:48Z 6222 followers, 2061 engagements
"Single study is enough for approval Very positive for $AXSM (ADA) $PRAX (ET) $MLTX (HS)"
X Link 2025-12-04T20:09Z 6215 followers, 5814 engagements
"$BBIO ACH ph3 data in q1'26"
X Link 2025-12-04T20:49Z 6215 followers, 1970 engagements
"$PRAX SCN2A and SCN8A developmental and epileptic encephalopathies (DEEs) early stoped for efficacy It's NaV channel so we may see some sympathy in $XENE"
X Link 2025-12-04T22:18Z 6222 followers, 5292 engagements
"$VKTX Todays FDA ruling about single trail requirement could speed up the drug approval process. Hope the pre-NDA FDA meeting will confirm that"
X Link 2025-12-05T01:37Z 6222 followers, 5166 engagements
"$ABVX Good point why $ABBV isn't a potential aquirer. IMO nobody currently is before the maintenance data due to some concerns about elevated miR-124 level. Could it bring surprises in long term like cardiac issues Long-term safety data are needed before any BO"
X Link 2025-12-05T04:58Z 6222 followers, 10.2K engagements
"$KRYS Retweeting a post which got X like X retweet X reply Many missed the point that the PTD from FDA is a game changer making any future NDAs faster and with higher probability of approval And the stock is up 50%+ since then"
X Link 2025-12-05T18:21Z 6215 followers, 3064 engagements
"@physioo Thanks $KRYS is not a popular name Which is strange because it's text book investment for small investors- first and only treatment in something Plus HSV platform nobody even consider to develop Monopoly in its purest form"
X Link 2025-12-06T00:55Z 6215 followers, XXX engagements
"$PRAX H.C.W: the pipeline is overlooked & underappreciated "We can't recall an instance where a biotech company got its first two approvals of drugs developed organically and both with blockbuster potential within a span of just a few months" Still not approved but on the way"
X Link 2025-12-06T12:20Z 6222 followers, 3126 engagements
"Two interesting data tomorrow Dec 7'25. $KURA Ph X Ziftomenib data (MEN1 Inhibitor - Small Molecule) in Acute Myeloid Leukemia $NRIX Ph X Waldenstrom Macroglobulinemia Data for Bexobrutideg (Btk Degrader - Small Molecule)"
X Link 2025-12-07T13:54Z 6222 followers, 2941 engagements
"$VTYX S1P1 vs $ABVX miR-124 Data looks comparable but VTYX program is practically on hold until they found a partner While data were promising they probably decided that going after NLRP3 is less risky Note that S1P1 & miR-124 both might have theoretically cardiac issues"
X Link 2025-12-07T22:10Z 6222 followers, 5797 engagements
"@WallStSai @GaryWhi13830766 @bioinvestor24 @pacha_8x IMO $PFE wanted low risk drug with some differenciation to $LLY. Small Molecule from $GPCR was too risky"
X Link 2025-12-08T01:15Z 6222 followers, 4819 engagements
"@Pharmdca Great point. Holding shares through binary events can be a nightmare That's why I prefer holding only options At bad data the loss is limited At good data - convert to shares at expiration to full position For example I have $PRAX Jan 30c. Small 10k lotto currently 150k"
X Link 2025-12-08T01:51Z 6219 followers, 1183 engagements
"$KYMR Stront AD data Mean XX% EASI reduction and mean XX% peak pruritus NRS reduction Patients with comorbid asthma with median XX% FeNO reduction in Allergic rhinitis with significant symptom and quality-of-life benefits Beat Dupi and on par with JAK 👍🤩 @BowTiedBiotech"
X Link 2025-12-08T13:20Z 6222 followers, 1373 engagements
"Long idea for 2026 Stay invested in protein degrader bios $KYMR $GLUE $NRIX The tweet to be revisited Dec 2026"
X Link 2025-12-08T15:04Z 6221 followers, 1755 engagements
"@DeepSouthDoctor Got it. Short position is a bit too risky to me. Big loss if the teade goes against you. Buying puts - risk is limited to the put price you pay. For example Dec XX puts are +70% today. Better return at low risk"
X Link 2025-12-09T15:39Z 6222 followers, XXX engagements
"Update top 10+10 (after $VRNA BO) $MDGL NASH $AXSM CNS MDD $XENE CNS seizures $KRYS GT DEB $VKTX metabolic $MIRM IBAT rare $MLTX I&I IL17A/F $SRRK TGFb $ALNY RNAi $RVMD RASmuti $BBIO $CRNX $CPRX $ABEO $KYMR $NUVL $IMCR $ACAD $CORT $NBIX"
X Link 2025-07-16T21:45Z 6223 followers, 42.1K engagements
"Q4 Update top 10+10 $MDGL NASH $AXSM CNS MDD $XENE CNS seizures $KRYS GT DEB $MIRM IBAT rare $RVMD RASmuti $CRNX endocrine $BBIO ATTR $SRRK TGFb $ALNY RNAi $CPRX $ABEO $CORT $KYMR $NUVL $QURE $IMCR $NBIX $VKTX $MLYS"
X Link 2025-09-30T14:34Z 6225 followers, 18.8K engagements
"$CRNX vs $TGTX pipeline"
X Link 2025-11-08T15:43Z 6223 followers, 5050 engagements
"@bioinvestor24 $TNGX is more advanced in PRMT5"
X Link 2025-12-01T03:00Z 6223 followers, XXX engagements
"$IDYA Collaboration Termination: GSK ended its agreement with Ideaya Biosciences for two clinical programs Pol Theya & Werner Hmm not a good news"
X Link 2025-12-05T23:51Z 6223 followers, 15.4K engagements
"$ABEO first patient treatment with RDEB It company milestone Reminder- each treatment is 3.1M so easy to became profitable in short term Stayed tuned for the next two ERs I believe double digit by mid 2026"
X Link 2025-12-08T13:41Z 6223 followers, 2677 engagements
"$GPCR Loking into GPCR data (oral GLP1) I start thinking that $PFE made another strategic mistake BTW selling GPCR at 5B mc is like missing half of the potential profit $MTSR got 9B for long acting peptide injection"
X Link 2025-12-08T15:22Z 6223 followers, 3782 engagements
"$VTYX Interesting option play 5000 call contracts Mar 10c at ask for 1225K 5000 put contracts Mar 7.5p at bit for 750K It looks buying XX calls and selling XXX puts for total 500k Winn XX a loss X @grok is this trade bullish or bearish"
X Link 2025-12-08T18:27Z 6225 followers, 4645 engagements
"Capital raise of all winners today $KYMR 500M cash after that 1.1B $GPCR 500M cash after that 1.3B $WVE 250M cash after that 450M $FULC 150M cash after that 350M $NRIX no raise cash 430M So investors has to find 3B. Getting it from other bios We may have a few -ve days"
X Link 2025-12-08T21:44Z 6225 followers, 13.3K engagements
"$XENE Epilepcy OLE data Monthly reductions in seizure frequency of XXXX% among participants treated for XX months with XX% achieving X year of seizure freedom"
X Link 2025-12-08T22:52Z 6225 followers, 1488 engagements
"$BHVN MDD ph2 data with Kv7 activator anytime now (expected q4'25) $XENE had mixed ph2 data with the same target last year in general positive. The bar is set so BHVN shoukd beat that or"
X Link 2025-12-09T14:11Z 6225 followers, 4768 engagements
"Capital raise - all upsized small discount - strong demand $KYMR 500M -602M @ $XX /-1% $GPCR 500M -650M @ $XX /-3% $WVE 250M -350M @ $XX /-11% $FULC 150M- 175M @ $XXXX /-7% $DYN 300M -350M @ $XXXX / X% $VERA 200M -260M @ $XXXX /-7% $TERN 400M -650M @ $XX / -7%"
X Link 2025-12-10T13:26Z 6225 followers, 4451 engagements
"$ABVX BO price is leaked- $XXX no CRV"
X Link 2025-12-10T15:09Z 6225 followers, 11.5K engagements